Smoke Inhalation Patients | European Survey: Risk of Cyanide Poisoning in Smoke Inhalation
Smoke Inhalation Patients research study
What is the primary objective of this study?
Cyanide poisoning is commonly viewed as a rare but dramatic event, occurring in industrial or laboratory settings as the result of accidental releases of hydrogen cyanide (HCN) gas (e.g. in the case of fire) or salts in the case of suicide attempts. In fact, cyanide poisoning is considerably more common than is generally appreciated. Multiple clinical and post-mortal studies have demonstrated that HCN contributes to the toxicity of fire smoke. Cyanide acts primarily through its strong affinity for the iron-containing heme moiety, binding to numerous critical enzyme systems in the body and rendering them inactive. Of late, increasing attention has been paid to the relationship of cyanide and nitric oxide. The interactions appear to be complex, with cyanide inducing nitric oxide production by binding to N-methyl-D-aspartate (NMDA) receptors, as well as binding to nitric oxide synthase. The latter may be overcome by the presence of nitric oxide synthase inhibitors. Probably, the majority of the cyanide poisoning cases are due to smoke inhalation in closed-space fires. So far, there are no clear data available on the prevalence of cyanide poisoning in smoke inhalation. This information would be of great interest for all emergency physicians since a proven or supposed cyanide poisoning does not only requires an intensive supportive care, including the administration of supplemental oxygen and artificial ventilation, blood pressure support, and anticonvulsants, but also a rapid administration of a cyanide antidote. Therefore, it is the goal of this survey to assess the prevalence of cyanide poisoning in smoke inhalation victims. Only the data of patients with a cyanide measurement before specific antidote treatment will be included
Who is eligible to participate?
Inclusion Criteria: - Closed space fire, Soot deposits, Altered mental status - Blood specimen before intravenous antidote treatment (cyanide measurement) - Known delay between end of smoke exposure and blood sampling - Malaise and/or Headache and/or Altered mental status in fire workers Exclusion Criteria: - Pregnancy - Multiple trauma, Blast - Patient pronounced dead at scene without resuscitation attempt - Patient in whom the time elapsed between the end of exposure and blood sampling is greater than 2 hours
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Smoke Inhalation Patients
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Other:There is no intervention planned (observational)No intervention foreseen
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Smoke Inhalation patientsClosed space fire, Soot deposits, Altered mental status Blood specimen before intravenous antidote treatment (cyanide measurement) Known delay between end of smoke exposure and blood sampling
Start Date: April 2009
Completed Date: July 2012
Primary Outcome: Overall Survival After 24 Hours
Study sponsors, principal investigator, and references
Principal Investigator: Thomas Zilker, Prof.
Lead Sponsor: Dr. Ernst MW Koch
Geldner G, Koch EM, Gottwald-Hostalek U, Baud F, Burillo G, Fauville JP, Levi F, Locatelli C, Zilker T. Report on a study of fires with smoke gas development : determination of blood cyanide levels, clinical signs and laboratory values in victims. Anaesthesist. 2013 Aug;62(8):609-16. doi: 10.1007/s00101-013-2209-3. Epub 2013 Aug 7.